SD-OCT provides better quality images of chorodial osteoma

Article

Spectral domain-optical coherence tomography (SD-OCT) provides higher resolution images of chorodial osteoma compared with time domain-OCT, reveals a study published in the British Journal of Ophthalmology.

Spectral domain-optical coherence tomography (SD-OCT) provides higher resolution images of chorodial osteoma compared with time domain-OCT, reveals a study published in the British Journal of Ophthalmology.

Dr Paul T. Finger et al., The New York Eye Cancer Center, New York, USA, studied 11 chorodial osteoma patients in a retrospective chart review. The review included patient, clinical, ultrasonographic, photographic and SD-OCT imaging.

The results demonstrated that the mean basal diameters of tumours recorded by fundus photography and ultrasound imaging were 5.2 mm and 6.4 mm respectively. In two cases, tumours were SD-OCT hyporeflective, hyperreflective in two cases and SD-OCT isoreflective in seven cases. In four cases, the intrinsic reflectivity of the tumour was inhomogenous. Also, the remaining choroid was reduced by the tumour in eight patients. In five patients degenerative retinal changes were found.

The study gives a deeper insight into the pathophysiology and diagnosis of chorodial osteoma. The images provided by SD-OCT are deeper and are of a higher resolution compared to images provided by time domain-OCT.

Recent Videos
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
Brent Kramer, MD, of Vance Thompson Vision speaks at the 2024 AAO meeting
© 2025 MJH Life Sciences

All rights reserved.